1. �й�ҽѧ��ѧԺ����Э��ҽԺ, a. ��Ѫ���ڿ�; b. ҩ����, ���� 100730; 2. ��������������ҽԺҩ����,���� 850000; 3. ���ɹ������ѧ����ҽԺҩ����,���ɹ� ͨ�� 028007; 4. �㽭ʡ��ͬ��ҽԺҩ����, ���� 310012
Evaluation For a Pharmacist-Nurse Co-Managed Programonthe Management of Coronary Heart Disease
GU Qing1a, LIU Li2, HU Yang1b, JIANG Qiu-feng3, FENG Pin-pin4, MEI Dan1b*
1a. Department of Cardiology, 1b. Department of Pharmacy, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing 100730, China; 2. Department of Pharmacy,People's Hospital of Tibet Autonomous Region, Lasa 850000, China; 3. Department of Pharmacy,Affiliated Hospital of Inner Mongolia University for the Nationalities,Tongliao 028007, China; 4. Department of Pharmacy,Tongde Hospital of Zhejiang Province,Hangzhou 310012,China
Abstract��OBJECTIVE To investigate the clinical effect of pharmacist-nurse co-managed program on health education on the management of coronary heart disease. METHODS Consult literature related to pharmacists and nurses cooperation on health education for coronary heart disease patients, and combine actual clinical needs and work experience, pharmacist-nurse co-managed program on medication education of coronary heart disease was been preliminary established in cardiology department in our hospital. RESULTS The pharmacist-nurse co-managed program can improve the patients concern for pharmacological actions, dosage and precautions for drugs. Compared with the traditional nurses health education, pharmacist-nurse co-managed program significantly improved the drug compliance of patients from 31% to 92.5%. The 90% of the patients hope to accept long-term follow-up.The role of pharmacists improved in the health team. The clinical outcomes was improved. CONCLUSION Clinical pharmacists certainly play a role in the medical teams.Pharmacist-nurse co-managed program is effective in improving the clinical outcome and reduce the adverse drug reactions. A long-term follow-up system is needed in the future.
Committee of Exprorts on Rational Drug Use National Health And Family Planning Commission of The P.R China Chinese Pharmacists Association. Guidelines for rational use of coronary heart disease[J]. Chin J Frontiers Med Sci(�й�ҽѧǰ����־),2016,8(6):1.
[2]
CHEN W W, GAO R L, LIU L S, et al. Summary of Chinese cardiovascular disease report 2017[J]. Chin Circul J(�й�ѭ����־), 2018, 33 (6):1-8.
[3]
BRITTANY D, ORISE F. Patient Safety: The Key Role of the Clinical Pharmacist[J/OL]. ODPHP, 2016[2016-03-14]. https://health.gov/news/blog/2016/03/patient-safety-the-key-role-of-the-clinical-pharmacist.
[4]
National health and family planning commission disease prevention and control bureau.Report on Nutrition and Chronic Diseases of Chinese Residents(2015) (�й�����Ӫ�������Բ�״������)[M]. Beijing:People's Medical Publishing House, 2015:33-50.
[5]
GE J B, XU Y J. Internal Medicine(�ڿ�ѧ) [M]. 8th ed. Beijing: People's Medical Publishing House, 2013:231.
[6]
YU H, ZHOU Y G, LI X W, et al. Effect of strengthened drug education by clinical pharmacist on survival, rehospitalization and reoperationrate of coronary heartdisease patients[J]. Chin J Pharmacov(�й�ҩ�ﾯ��),2014,11(1):47-49.
[7]
WU L J, HONG N, CHEN Y, et al. Early interventioneffect of CCU-ward-out-hospital contionous management mode for secondary prevention goal of patients with ACS[J]. Chin Nur Res(�����о�), 2015, 29(11):4188-4189.
[8]
LIN W S, LIU H. Exploration of working mode of health education of clinical pharmacists in hospitalized patients with cerebrovascular disease[J]. Chin J Pharmacov(�й�ҩ�ﾯ��),2012,9(8):490-492.
[9]
GUO Y F, HU D Y, YAN X W, et al. National consensus on the safety evaluation of statin drugs [J]. Chin J Cardiol(�л���Ѫ�ܲ���־),2014,42(11):890-894.
[10]
ZHAO Y J, WEI J G. Discussion on the time of taking aspirin enteric tablets[J]. Chin Prac Med(�й�ʵ��ҽҩ),2011,6(34):139-140.
[11]
ZHANG M M, ZHANG H J, ZHAI S D. Literature review of improving medication outcomes by collaborating pharmacists and nurses[J]. Chin J Drug Appl Monit(�й�ҩ��Ӧ������), 2012,9(3):173-175.
[12]
MCLEAN D L, MCALISTER F A, JOHNSON J A, et al. A randomizedtrial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN)[J]. Arch Intern Med, 2008, 168(21):2355-2361.
[13]
Translated by DUAN J L. Pharmacists Talking with Patients-a Guide to Patient Counseling (ҩ��ʦ�뻼�߹�ָͨ��)[M]. 2th ed. Beijing:People's Military Medical Press,2012:32-36.
[14]
DING Q, CHEN S C. Role of clinical pharmacists on chronic disease management[J]. Chin J Health Edu(���������),2015,31(1):90-92.
[15]
CARTER B L, BOSWORTH H B, GREEN B B, et al. The role of the pharmacist, nurse, and teamwork in hypertension therapy[J]. The J Clin Hypert, 2012,14(1):51-65.
2018, Vol. 53 
